SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001558370-20-004979
Filing Date
2020-05-04
Accepted
2020-05-04 07:57:25
Documents
47
Period of Report
2020-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q mrms-20200331x10q.htm 10-Q 982742
2 EX-31.1 mrms-20200331ex3110e4ab1.htm EX-31.1 15203
3 EX-31.2 mrms-20200331ex31213f47b.htm EX-31.2 15373
4 EX-32.1 mrms-20200331ex321bc1d99.htm EX-32.1 8374
5 GRAPHIC mrms20200331x10q001.jpg GRAPHIC 23678
6 GRAPHIC mrms20200331x10q002.jpg GRAPHIC 883041
  Complete submission text file 0001558370-20-004979.txt   4512333

Data Files

Seq Description Document Type Size
7 EX-101.INS mrms-20200331.xml EX-101.INS 562931
8 EX-101.SCH mrms-20200331.xsd EX-101.SCH 24050
9 EX-101.CAL mrms-20200331_cal.xml EX-101.CAL 38130
10 EX-101.DEF mrms-20200331_def.xml EX-101.DEF 80283
11 EX-101.LAB mrms-20200331_lab.xml EX-101.LAB 266932
12 EX-101.PRE mrms-20200331_pre.xml EX-101.PRE 175546
Mailing Address 5 RADNOR CORPORATE CENTER SUITE 500 100 MATSONFORD RD RADNOR PA 19087
Business Address 5 RADNOR CORPORATE CENTER SUITE 500 100 MATSONFORD RD RADNOR PA 19087 484-801-4670
MARINUS PHARMACEUTICALS INC (Filer) CIK: 0001267813 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36576 | Film No.: 20842808
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences